Ross T A MacGillivray

Title: Ross T A MacGillivray: Innovator in Recombinant Transferrins

Introduction

Ross T A MacGillivray is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of recombinant transferrins. His work has implications for medical therapies and tissue culture applications.

Latest Patents

MacGillivray holds a patent for "Recombinant transferrins, transferrin half-molecules and mutants thereof." This patent describes recombinant transferrin molecules that are expressed in functional form by stable eukaryotic cell lines, such as baby hamster kidney cells transformed with an expression vector encoding the recombinant molecule. The recombinant transferrins can be utilized in metal chelation therapy to bind and eliminate excess toxic metals in patients suffering from metal overloads. Additionally, they can serve as supplements or replacements in tissue culture media.

Career Highlights

Throughout his career, MacGillivray has been associated with prestigious institutions, including the University of British Columbia and the University of Vermont. His research has advanced the understanding of transferrin's role in metal binding and its potential therapeutic applications.

Collaborations

Some of his notable coworkers include Anne B Mason and Robert C Woodworth. Their collaborative efforts have contributed to the advancements in the field of recombinant proteins and their applications.

Conclusion

Ross T A MacGillivray's innovative work in recombinant transferrins showcases his dedication to advancing biochemistry and medical therapies. His contributions continue to impact the field positively.